Ischemia-Modified Albumin is Increased in Patients With Unstable Angina: A new Potential Diagnostic Biomarker of This Acute Coronary Syndrome?

Authors:

Abstract
To examine changes in serum ischemia-modified albumin (IMA) concentrations in patients with unstable angina (UA) and stable angina (SA) and their potential clinical significance. Eighty-eight subjects were divided into 3 groups: UA group (n=34), SA group (n=24), and healthy control group (n=30). Ischemia-modified albumin concentration was measured using an assay adapted to the Hitachi 7600 automated chemistry analyzer. Left ventricular ejection fraction (LVEF) and mural movement (MM) were assessed by echocardiography. IMA concentration was higher in UA patients than in SA patients or healthy controls (P0.05). IMA concentration was negatively correlated with LVEF in UA patients (r = −0.686, PP P<0.01). Ischemia-modified albumin concentration is increased significantly in UA patients. In addition, IMA is negatively correlated with abnormal LVEF, which may prove to be of clinical significance in the early diagnosis and stratification of risk in patients with acute coronary syndrome (ACS).

This publication has 14 references indexed in Scilit: